Basal-bolus Insulin Therapy Versus Standard Therapy for the Inpatient Management of Type 2 Diabetes: the IDA2 Study
Clinical trial NCT03244241 · UNKNOWN
Trial details
- NCT number
- NCT03244241
- Sponsor
- Merete Bechmann Christensen
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-01
- Primary completion
- 2018-04-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.